Get the Stockscreener App
2.065
2.22%
0.035
Autolus Therapeutics Plc Adr Stock (AUTL) Forecast
The Autolus Therapeutics Plc Adr (AUTL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.9489, representing a +91.23% increase from the current price of $2.065. The highest analyst price target is $4.4998, and the lowest is $3.3981.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AUTL Price Target
Average 3.7416
(+81.19% Upside)
Is Autolus Therapeutics Plc Adr (AUTL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 60.00 | Neutral |
| STOCH(9,6) | 34.58 | Neutral |
| STOCHRSI(14) | 5.9759 | Buy |
| MACD(12,26) | 0.1637 | Sell |
| ADX(14) | 40.69 | Buy |
| William %R | -50.00 | Neutral |
| CCI(14) | -16.40 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.193
Sell
|
2.0866
Sell
|
| MA20 |
1.963
Buy
|
1.9688
Buy
|
| MA50 |
1.5928
Buy
|
1.7856
Buy
|
| MA100 |
1.7308
Buy
|
1.9117
Buy
|
| MA200 |
2.5303
Sell
|
2.4841
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, AUTL could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 5 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on AUTL, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 60 indicates that AUTL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 34.58 indicates that AUTL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 5.9759 indicates that AUTL is oversold. This suggests that AUTL price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 40.69 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -16.4 indicates that AUTL is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term AUTL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Autolus Therapeutics Plc Adr financial reports and earnings history, Autolus Therapeutics Plc Adr (AUTL) stock could reach $20.78 by 2030, $18.72 by 2040 and $48.70 by 2050. See the projected annual prices until 2050 of the Autolus Therapeutics Plc Adr stock below:
- Autolus Therapeutics Plc Adr (AUTL) is expected to reach an average price of $4.9179 in 2035, with a high prediction of $7.298 and a low estimate of $5.6779. This indicates an $138.16% rise from the last recorded price of $2.065.
- Autolus Therapeutics Plc Adr (AUTL) stock is projected to chart a bullish course in 2040, with an average price target of $18.38, representing an $789.94% surge from its current level. The forecast ranges from a conservative $18.56 to a sky-high $18.72.
- Our analysts predict Autolus Therapeutics Plc Adr (AUTL) to jump 1,405% by 2045, soaring from $32.10 to an average price of $31.08, potentially reaching $32.07. While $32.10 is the low estimate, the potential upside is significant.
- Autolus Therapeutics Plc Adr (AUTL) stock is expected to climb by 2050, reaching an average of $47.45, a $2,198% jump from its current level. However, a wide range of estimates exists, with high and low targets of $48.70 and $47.91, respectively, highlighting the market's uncertainty.
Autolus Therapeutics Plc Adr Stock (AUTL) Year by Year Forecast
Autolus Therapeutics Plc Adr Stock (AUTL) Price Forecast for 2025
Autolus Therapeutics Plc Adr Stock (AUTL) is expected to reach an average price of $5.6068 in 2025, with a high prediction of $11.20 and a low estimate of $0.00871. This indicates an +171.51% rise from the last recorded price of $2.065.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $2.4098 | $3.3981 | $4.4998 | +16.69% |
| August, 2025 | $0.5397 | $0.1097 | $0.6453 | -73.86% |
| September, 2025 | $0.1303 | $1.5497 | $1.5503 | -93.69% |
| October, 2025 | $2.8947 | $0.00871 | $0.9423 | +40.18% |
| November, 2025 | $3.3647 | $2.0947 | $2.0147 | +62.94% |
| December, 2025 | $3.9497 | $3.0897 | $3.1497 | +91.27% |
Autolus Therapeutics Plc Adr Stock (AUTL) Price Forecast for 2026
The predicted value for Autolus Therapeutics Plc Adr (AUTL) in 2026 is set at an average of $5.8321. Estimates vary from a peak of $7.5396 to a trough of $4.1247, indicating an +182.43% surge from the present price of $2.065.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.9297 | $4.1247 | $3.2906 | +138.72% |
| February, 2026 | $5.6996 | $4.3846 | $4.8208 | +176.01% |
| March, 2026 | $5.0796 | $5.4596 | $4.9646 | +145.99% |
| April, 2026 | $6.6746 | $5.8346 | $5.9046 | +223.23% |
| May, 2026 | $6.7046 | $7.1546 | $6.8196 | +224.68% |
| June, 2026 | $7.7846 | $7.7396 | $7.4746 | +276.98% |
| July, 2026 | $6.9395 | $7.7396 | $7.5396 | +236.06% |
| August, 2026 | $5.1595 | $6.4495 | $6.1957 | +149.86% |
| September, 2026 | $5.6145 | $5.6145 | $5.6945 | +171.89% |
| October, 2026 | $6.3245 | $6.8495 | $6.6995 | +206.27% |
| November, 2026 | $5.3045 | $5.5545 | $6.2845 | +156.88% |
| December, 2026 | $5.3295 | $5.2795 | $5.2245 | +158.09% |
Autolus Therapeutics Plc Adr Stock (AUTL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Autolus Therapeutics Plc Adr (AUTL) is $6.0694, with a high forecast of $7.0043 and a low forecast of $5.1344. This indicates an +193.92% increase from the last price of $2.065.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.0894 | $5.339 | $5.4594 | +194.89% |
| February, 2027 | $5.2394 | $5.1344 | $5.8344 | +153.73% |
| March, 2027 | $5.7444 | $5.3794 | $4.9344 | +178.18% |
| April, 2027 | $6.5544 | $6.0155 | $6.0844 | +217.40% |
| May, 2027 | $6.4444 | $6.8144 | $6.8044 | +212.08% |
| June, 2027 | $6.9494 | $6.3144 | $6.6044 | +236.53% |
| July, 2027 | $6.0793 | $6.1044 | $6.4244 | +194.40% |
| August, 2027 | $6.6093 | $5.9193 | $6.0093 | +220.06% |
| September, 2027 | $7.1343 | $6.9542 | $7.0043 | +245.49% |
| October, 2027 | $7.3143 | $7.0693 | $6.9643 | +254.20% |
| November, 2027 | $6.3843 | $6.6593 | $6.7793 | +209.17% |
| December, 2027 | $5.4693 | $5.9393 | $6.0193 | +164.86% |
Autolus Therapeutics Plc Adr Stock (AUTL) Price Forecast for 2028
In 2028, Autolus Therapeutics Plc Adr (AUTL) is projected to reach an average price of $4.8217, with a high projection of $6.1242 and a low estimate of $3.5191. This indicates an +133.49% rise from the last price of $2.065.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.6392 | $5.6692 | $5.4292 | +173.09% |
| February, 2028 | $6.4592 | $5.9042 | $6.1242 | +212.80% |
| March, 2028 | $5.4742 | $5.4692 | $5.2942 | +165.10% |
| April, 2028 | $5.6042 | $5.9225 | $5.8092 | +171.39% |
| May, 2028 | $5.9642 | $5.4442 | $5.9742 | +188.82% |
| June, 2028 | $5.6092 | $5.7792 | $5.8542 | +171.63% |
| July, 2028 | $5.2091 | $5.4491 | $5.4942 | +152.26% |
| August, 2028 | $5.2141 | $5.3041 | $5.2341 | +152.50% |
| September, 2028 | $5.0741 | $5.1241 | $5.0191 | +145.72% |
| October, 2028 | $4.7841 | $4.8941 | $4.9491 | +131.68% |
| November, 2028 | $3.4991 | $3.6291 | $4.5391 | +69.45% |
| December, 2028 | $3.7991 | $3.5191 | $3.4991 | +83.97% |
Autolus Therapeutics Plc Adr Stock (AUTL) Price Forecast for 2029
The 2029 price forecast for Autolus Therapeutics Plc Adr Stock (AUTL) is $6.9606 on average, with a high prediction of $13.74 and a low estimate of $0.1811. This represents an +237.07% increase from the previous price of $2.065.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.674 | $2.804 | $3.4791 | +29.49% |
| February, 2029 | $2.494 | $2.579 | $2.749 | +20.78% |
| March, 2029 | $2.594 | $2.404 | $2.364 | +25.62% |
| April, 2029 | $2.894 | $3.114 | $2.949 | +40.15% |
| May, 2029 | $1.539 | $1.6577 | $2.604 | -25.47% |
| June, 2029 | $0.559 | $0.819 | $0.479 | -72.93% |
| July, 2029 | $1.9111 | $0.3661 | $2.4111 | -7.45% |
| August, 2029 | $1.7661 | $1.1011 | $3.0311 | -14.48% |
| September, 2029 | $2.0761 | $1.4161 | $3.2811 | +0.54% |
| October, 2029 | $2.5611 | $1.4861 | $2.8661 | +24.02% |
| November, 2029 | $0.9811 | $0.9461 | $2.8961 | -52.49% |
| December, 2029 | $15.49 | $0.1811 | $13.74 | +650.12% |
Autolus Therapeutics Plc Adr Stock (AUTL) Price Forecast for 2030
Autolus Therapeutics Plc Adr Stock (AUTL) is expected to reach an average price of $22.43 in 2030, with a high forecast of $28.00 and a low forecast of $16.87. This signifies an +986.43% surge from the last price of $2.065.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $22.91 | $16.87 | $20.78 | +1,009% |
| February, 2030 | $21.95 | $22.54 | $21.52 | +962.95% |
| March, 2030 | $22.68 | $23.30 | $22.36 | +998.30% |
| April, 2030 | $26.87 | $26.68 | $26.28 | +1,201% |
| May, 2030 | $24.18 | $24.76 | $23.76 | +1,071% |
| June, 2030 | $22.71 | $23.87 | $23.60 | +999.75% |
| July, 2030 | $22.81 | $23.92 | $23.25 | +1,005% |
| August, 2030 | $22.16 | $20.76 | $21.14 | +973.11% |
| September, 2030 | $22.07 | $21.65 | $21.45 | +968.75% |
| October, 2030 | $23.04 | $22.38 | $24.04 | +1,016% |
| November, 2030 | $28.09 | $24.14 | $25.89 | +1,260% |
| December, 2030 | $27.93 | $28.14 | $28.00 | +1,253% |
1.59%
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):